Genedrive PLC - Manchester-based molecular diagnostics firm - Completes assay design for point-of-care solution for Covid-19 testing and is generating promising analytical data in line with market requirements.
Targeting the end of 2020 for completion of product evaluations, with the full release of the final CE Marked system in the first quarter of the 2021 financial year.
Current stock price: 105.25 pence
Year-to-date change: up sharply from 22.50p
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


(Sharecast News) - Genedrive said on Friday that it had received a research and development tax credit refund of about £0.76m from HMRC.


(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


(Sharecast News) - Genedrive said on Friday that it had received a research and development tax credit refund of about £0.76m from HMRC.


(Alliance News) - Genedrive PLC on Tuesday said it has appointed a major shareholder to its board, as it reported that Chair Ian Gilham plans to step ...


(Sharecast News) - Genedrive said on Tuesday that the University Hospitals Sussex NHS Foundation Trust had moved its MT-RNR1 test into routine clinica...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...


(Alliance News) - Genedrive PLC on Monday said it is "well positioned" to build on the progress achieved during 2025.


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: